12 Stocks Insiders are Buying Now
In this article, we will look at the 12 stocks insiders are buying now. If you want to explore similar stocks, you can also take a look at 5 Stocks Insiders are Buying Now. Investing in stocks thatin...
- Supported exchanges /
- NASDAQ /
- AURA.NASDAQ
Aura Biosciences Inc (AURA NASDAQ) stock market data APIs
$8.98
-0.09(-1%)
as of September 11, 2024
Price chart is built with Anychart
Aura Biosciences, Inc., a clinical-stage biotechnology company, develops precision immunotherapies to treat a range of solid tumors. The company's proprietary platform enables the targeting of a range of solid tumors using virus-like particles conjugated with drugs or loaded with nucleic acids to create virus-like drug conjugates. Its lead candidate is bel-sar, which is in late-stage clinical development for the treatment of patients with primary choroidal melanoma and other ocular oncology indications, as well as in early-stage clinical development in bladder cancer. The company also focuses on assessing the safety and efficacy of bel-sar in treating a range of other solid tumors, including bladder cancer as an alternative to bacillus calmette"guérin therapy. Aura Biosciences, Inc. was incorporated in 2009 and is headquartered in Boston, Massachusetts.
Aura Biosciences Inc Financial Data Overview
| 9.07 | |
| 8.98 | |
| - | |
| 9.3 | |
| 8.66 | |
| 5.99-12.35 | |
| 447 M | |
| 49 606 K | |
| 0 | |
| -0.41 | |
| 0.35 |
Our easy-to-use no-coding solutions help you get the data effortlessly:
No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.
General: {
Code:
'AURA',
Type:
'Common Stock',
Name:
'Aura Biosciences Inc',
Exchange:
'NASDAQ',
CurrencyCode:
'USD',
CurrencyName:
'US Dollar',
CurrencySymbol:
'$',
CountryName:
'USA',
CountryISO:
'US',
OpenFigi:
'BBG00226DGM5',
ISIN:
NULL,
CUSIP:
NULL,
CIK:
'1501796',
EmployerIdNumber:
NULL,
FiscalYearEnd:
'December',
IPODate:
'2021-10-29',
InternationalDomestic:
NULL,
Sector:
'Healthcare',
Industry:
'Biotechnology',
HomeCategory:
NULL,
IsDelisted:
false,
}
Aura Biosciences Inc Fundamental Data is available in our Financial Data APIs
- Net Revenue 0
- EBITDA -89 062 000
- Earnings Per Share -1.79
- Income Statements
- Balance Sheets
- Cash flows
of Fundamental API Data
Get Aura Biosciences Inc Earnings via APIs
- Latest Release 2024-08-07
- EPS/Forecast -0.45
Get Aura Biosciences Inc End-of-day Data via APIs
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Get Aura Biosciences Inc latest news via APIs
Positive Data Presentations at AAO Annual Meeting Demonstrate Utility and Versatility of Clearside Biomedical’s Proprietary Suprachoroidal Space Platform
- ADMINISTRATION
- CLEARSIDE
- CLEARSIDE BIOMEDICAL
- EYE PHYSICIANS AND SURGEONS
- INC
- SCS MICROINJECTOR
- SUPRACHOROIDAL
- THOMAS A. CIULLA
Do you have any questions?
Our 24/7 support would be happy to assist you via chat or email:
support@eodhistoricaldata.comVisit also:
